CJC-1295 No DAC

For Laboratory Research Use Only — Not for Human or Veterinary Use.

Standard (< 1,000 vials)$340/kit

Volume (1,000+ vials)$260/kit

Quantity (kits)

= 10 vials

Minimum order: 100 vials total. Mix and match across all products.

I confirm this order is for laboratory research use only.For Laboratory Research Use Only — Not for Human or Veterinary Use. By checking this box you affirm this product will not be used for human or animal administration.

Specifications

CAS Number	863288-34-0
Molecular Formula	C152H252N44O42
Molecular Weight	3367.90 g/mol
Purity	≥98% (HPLC)
Form	Lyophilized Powder
Storage	-20°C, desiccated, protected from light
Reconstitution	Bacteriostatic water

Certificate of Analysis

Lot documentation

Every production lot is independently third-party tested. A batch-specific Certificate of Analysis — documenting HPLC purity, mass spectrometry identity confirmation, and net peptide content — is issued with every shipment. View a sample COA to see the format.

View Sample COA About our testing →

Research context

CJC-1295 without DAC, also known as Modified GRF (1-29), is a synthetic 29-amino-acid peptide analog of the N-terminal fragment of growth hormone-releasing hormone (GHRH). It carries four amino acid substitutions relative to native GRF(1-29) that have been reported, in vitro and in animal models, to increase enzymatic stability and binding at the GHRH receptor, a class B G-protein-coupled receptor expressed on anterior pituitary somatotrophs.

Research in isolated pituitary cell preparations and rodent models has examined its binding to the GHRH receptor and the resulting activation of adenylate cyclase and cAMP-mediated signaling. Analytical characterization of the peptide has been performed using reversed-phase HPLC and mass spectrometry to confirm identity, sequence, and purity.

This compound is supplied strictly for in-vitro laboratory research and analytical use. It is not intended for human or veterinary administration, and no statements herein constitute a therapeutic claim or dosing recommendation.